APA (7th ed.) Citation

SS, W., ED, L., J, S., B, P., JA, K., N, S., . . . J, G. (2023). Survival Outcomes of Advanced Thyroid Cancer Enriched in Brain Metastases Following Treatment With Small Molecule Inhibitors. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 29(11), 881. https://doi.org/10.1016/j.eprac.2023.08.003

Chicago Style (17th ed.) Citation

SS, Wu, et al. "Survival Outcomes of Advanced Thyroid Cancer Enriched in Brain Metastases Following Treatment With Small Molecule Inhibitors." Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 29, no. 11 (2023): 881. https://doi.org/10.1016/j.eprac.2023.08.003.

MLA (9th ed.) Citation

SS, Wu, et al. "Survival Outcomes of Advanced Thyroid Cancer Enriched in Brain Metastases Following Treatment With Small Molecule Inhibitors." Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, vol. 29, no. 11, 2023, p. 881, https://doi.org/10.1016/j.eprac.2023.08.003.